Recombinant Mouse Tumor necrosis factor ligand superfamily member 6 (Faslg)

What is Recombinant Mouse Fas Ligand/TNFSF6 and what are its key biological functions?

Fas Ligand (FasL), also known as CD178, CD95L, or TNFSF6, is a 40 kDa type II transmembrane protein belonging to the TNF superfamily. Its primary function is inducing apoptosis in cells expressing its receptor, Fas (CD95). This interaction plays crucial roles in:

• Development, homeostasis, and function of the immune system

• Maintaining immune tolerance and self-tolerance of lymphocytes

• Establishing immune privilege in certain tissues

• Limiting lymphoid expansion via lymphoid-lymphoid interactions

The mature mouse FasL consists of a 179 amino acid extracellular domain (ECD), a 22 amino acid transmembrane segment, and a 78 amino acid cytoplasmic domain. Within the ECD, mouse FasL shares 81% and 93% amino acid sequence identity with human and rat FasL, respectively .

What are the structural variants of Recombinant Mouse FasL and how do they differ functionally?

Different recombinant forms of mouse FasL are available for research, each with distinct structural characteristics and functional properties:

The trimerization domain in the 6128-SA variant allows for more stable formation of the homotrimer and increased biological activity compared to other forms .

How do membrane-bound and soluble forms of FasL differ in their biological activities?

Membrane-bound and soluble FasL exhibit significant differences in their biological activities:

• Membrane-bound FasL:

  • Primary activator of Fas receptor

  • Potent inducer of apoptosis

  • Expressed predominantly on activated T cells and NK cells

• Soluble FasL (sFasL):

  • Generated by metalloproteinase cleavage of membrane-bound FasL

  • Exists primarily as a non-covalently linked homotrimer

  • Significantly reduced cytotoxicity compared to membrane-bound form

  • May competitively inhibit the killing effect of membrane FasL

  • Functions as a chemoattractant for neutrophils, suggesting a proinflammatory role

These functional differences must be considered when designing experiments to study FasL-mediated processes.

What methodologies are most effective for assessing FasL-induced apoptosis in experimental systems?

To effectively measure FasL-induced apoptosis, researchers should employ multiple complementary techniques:

• Cell viability assays:

  • MTT or WST-1 assays for metabolic activity

  • Trypan blue exclusion for membrane integrity

• Apoptosis-specific assays:

  • Annexin V/PI staining and flow cytometry to distinguish early/late apoptosis

  • TUNEL assay for DNA fragmentation

  • Caspase activity assays (particularly caspase-3, -8, and -9)

  • DNA ladder analysis by gel electrophoresis

• Positive controls and validation:

  • Include a known apoptosis inducer (e.g., staurosporine)

  • Confirm with multiple methodologies

  • Use Fas-expressing cell lines (e.g., Jurkat T cells)

For recombinant FasL (Catalog # 6128-SA), the ED50 for cytotoxic effect is 1-8 ng/mL when used with 2.5 μg/mL of a cross-linking antibody (Mouse Anti-Hemagglutinin/HA Peptide Monoclonal Antibody) .

How can researchers optimize cross-linking strategies to enhance soluble FasL activity?

Cross-linking is critical for enhancing the activity of soluble recombinant FasL:

• Antibody cross-linking:

  • For hemagglutinin-tagged FasL (6128-SA): Use anti-HA antibody at 2.5 μg/mL with FasL at 1-8 ng/mL

  • For His-tagged FasL (526-SA): Use anti-polyHistidine antibody at 10 μg/mL with FasL at 0.25-1.5 μg/mL

• Pre-incubation approach:

  • Mix FasL with cross-linking antibody

  • Incubate at room temperature for 15-30 minutes before adding to cells

  • Maintain consistent antibody:FasL ratio across experiments

• Secondary cross-linking:

  • For enhanced activity, consider using protein G or secondary antibodies

  • This creates larger complexes that more effectively mimic membrane-bound FasL

• Time course optimization:

  • Determine optimal incubation times (typically 6-24 hours)

  • Monitor apoptosis at multiple timepoints to capture peak activity

What are the key considerations for using Recombinant Mouse FasL in studies of immune privilege?

When investigating immune privilege using recombinant FasL, researchers should consider:

• Tissue-specific expression patterns:

  • FasL is naturally expressed in immune-privileged sites (e.g., eye, testes, brain)

  • These tissues protect themselves by killing infiltrating Fas-positive lymphocytes

• Experimental design considerations:

  • Include appropriate controls for FasL specificity (e.g., FasL-deficient tissues)

  • Validate with FasL-blocking antibodies

  • Consider the presence of decoy receptors like DcR3 that can interfere with FasL-induced apoptosis

• Dual nature of FasL function:

  • While FasL can protect tissues from immune assault via lymphocyte apoptosis

  • It can also damage Fas-expressing tissues

  • In the absence of TGF-beta, FasL/Fas interactions may promote neutrophil-mediated inflammatory responses

This dual "privilege and peril" nature of FasL must be accounted for in experimental designs .

How can mouse models with FasL mutations inform our understanding of FasL function?

Mouse models with FasL mutations provide valuable insights into FasL biology:

• gld (generalized lymphoproliferative disease) mice:

  • Carry a point mutation in FasL gene

  • Exhibit severe lymphoproliferation and systemic autoimmunity

  • Serve as models for human autoimmune lymphoproliferative syndrome (ALPS)

  • Show the importance of FasL in preventing autoimmunity

• Experimental approaches using these models:

  • Cell transfer experiments to determine tissue-specific effects

  • Bone marrow chimeras to distinguish hematopoietic vs. non-hematopoietic roles

  • Conditional knockout strategies for temporal control of FasL expression

• Research applications:

  • Study FasL role in tumor immunity

  • Investigate autoimmune pathogenesis

  • Develop transplantation tolerance approaches

How can Recombinant Mouse FasL be used to investigate cancer biology and potential therapeutic approaches?

FasL plays complex roles in cancer biology that can be investigated using recombinant proteins:

• Tumor immune evasion:

  • Tumor cells can upregulate FasL to induce apoptosis in tumor-infiltrating lymphocytes

  • This "counterattack" mechanism helps tumors evade immune surveillance

  • Can be studied using co-culture systems with recombinant FasL as control

• Experimental applications:

  • Use recombinant FasL to mimic tumor microenvironment

  • Study differential sensitivity of immune cell subsets to FasL-induced apoptosis

  • Test FasL-blocking strategies to enhance anti-tumor immunity

• Therapeutic implications:

  • Blockade of Fas signaling in breast cancer cells suppresses tumor growth and metastasis via disruption of cancer-related inflammation

  • In experimental models, manipulating the FasL/Fas axis influences metastatic potential

Research has demonstrated that blocking Fas signaling can disrupt cancer-related inflammation, suggesting potential therapeutic approaches targeting this pathway .

What are the optimal storage and handling conditions for maintaining Recombinant Mouse FasL activity?

To maintain optimal activity of Recombinant Mouse FasL:

• Storage recommendations:

  • Store lyophilized protein at -20°C to -80°C

  • After reconstitution, aliquot and store at -80°C (avoid repeated freeze-thaw cycles)

  • Working solutions should be prepared fresh

• Reconstitution guidelines:

  • Use sterile, buffer-appropriate solutions (typically PBS with 0.1% BSA)

  • Allow protein to equilibrate to room temperature before reconstitution

  • Gently agitate; avoid vortexing to prevent protein denaturation

• Quality control:

  • Verify activity with cytotoxicity assays before conducting critical experiments

  • Include negative controls (e.g., heat-inactivated FasL)

What cell types and experimental models are most appropriate for studying FasL function?

Select appropriate models based on research objectives:

• Cell lines for in vitro studies:

  • A20 mouse B cell lymphoma cells express mouse Fas but show variable sensitivity

  • Jurkat T cells are highly sensitive to FasL-induced apoptosis

  • L929 fibroblasts transfected with Fas can be used for specificity studies

• Primary cells:

  • Activated T cells express both Fas and FasL

  • Neutrophils for studying chemotactic responses

  • Hepatocytes for tissue damage models

• Animal models:

  • Wild-type mice for normal physiological studies

  • gld mice to study consequences of FasL mutation

  • Conditional knockout models for tissue-specific effects

How can researchers troubleshoot variable or unexpected results when working with Recombinant Mouse FasL?

When encountering variable results:

• Common issues and solutions:

  • Insufficient cross-linking: Optimize antibody concentration and pre-incubation time

  • Target cell resistance: Verify Fas expression on target cells

  • Loss of activity: Minimize freeze-thaw cycles, prepare fresh working solutions

• Experimental controls:

  • Include positive controls (known FasL-sensitive cells)

  • Include negative controls (FasL-resistant cells or blocking antibodies)

  • Validate with multiple apoptosis detection methods

• Technical considerations:

  • Ensure consistent cell density and culture conditions

  • Account for passage number of cell lines

  • Validate protein activity before critical experiments

By implementing these troubleshooting strategies, researchers can enhance the reliability and reproducibility of their FasL experiments.

How does FasL contribute to immune system homeostasis and autoimmunity?

FasL plays essential roles in immune regulation:

• Lymphocyte homeostasis:

  • Limits lymphoid expansion through lymphoid-lymphoid interactions

  • Contributes to activation-induced cell death (AICD) of T cells

  • Maintains self-tolerance by eliminating autoreactive lymphocytes

• Autoimmune pathogenesis:

  • Defects in FasL (as in gld mice) cause severe lymphoproliferation and systemic autoimmunity

  • These models mirror human autoimmune lymphoproliferative syndrome

  • Recombinant FasL can be used to study these processes in vitro

• Research applications:

  • Using recombinant FasL to study T cell apoptosis sensitivity

  • Investigating the role of FasL in regulatory T cell function

  • Developing therapeutic approaches for autoimmune diseases

What role does FasL play in neutrophil recruitment and inflammatory responses?

Beyond its apoptotic function, FasL exhibits important proinflammatory activities:

• Neutrophil recruitment:

  • Soluble FasL functions as a potent chemoattractant for neutrophils

  • In the absence of TGF-beta, FasL/Fas interactions promote neutrophil-mediated inflammatory responses

• Inflammation regulation:

  • Paradoxically, FasL can both promote and limit inflammation

  • Membrane-bound versus soluble forms have different inflammatory effects

  • Neutrophils play unexpected roles in clearing apoptotic cells, as demonstrated in hepatocyte models

• Experimental approaches:

  • Neutrophil migration assays with recombinant FasL

  • In vivo models of inflammation with FasL administration

  • Analysis of neutrophil-mediated tissue damage versus repair

How can researchers utilize Recombinant Mouse FasL to study sex differences in disease susceptibility?

Recent research highlights important sex differences in FasL biology:

• Sex bias in disease processes:

  • The innate immune system and TRAIL-BCL-XL axis mediate sex bias in lung cancer

  • FasL-related pathways confer differential therapeutic vulnerability in females versus males

• Experimental design considerations:

  • Include both male and female models in research

  • Analyze sex-specific responses to FasL-induced apoptosis

  • Consider hormonal influences on FasL expression and signaling

• Research applications:

  • Using recombinant FasL to compare apoptotic sensitivity between male and female cells

  • Investigating sex-specific therapeutic approaches targeting the FasL/Fas pathway

  • Developing personalized medicine approaches based on sex differences in FasL signaling

By incorporating these considerations into experimental design, researchers can better understand how FasL contributes to sex differences in disease susceptibility and treatment responses.

What are emerging applications for Recombinant Mouse FasL in tissue engineering and regenerative medicine?

Emerging research suggests potential applications for FasL in regenerative medicine:

• Immune-privileged grafts:

  • Engineering tissues to express FasL may protect transplants from immune rejection

  • Creating localized immune privilege without systemic immunosuppression

  • Balancing immune evasion with the risk of inflammatory responses

• Tissue remodeling:

  • Controlled apoptosis via FasL for tissue sculpting during regeneration

  • Regulating stem cell populations through selective apoptosis

• Research approaches:

  • Testing FasL-expressing biomaterials in transplantation models

  • Developing controlled-release systems for recombinant FasL

  • Investigating combination approaches with immunomodulatory factors

These applications require careful consideration of FasL's dual roles in immune privilege and inflammation .

How might advances in protein engineering enhance the utility of Recombinant Mouse FasL for research?

Protein engineering offers opportunities to create improved FasL variants:

• Enhanced stability variants:

  • Engineered disulfide bonds for improved thermal stability

  • Modified trimeric forms with enhanced half-life

  • Domain-specific modifications to preserve specific functions

• Activity-tuned variants:

  • Selective agonists that preferentially activate specific Fas-mediated pathways

  • Variants with tunable apoptotic versus inflammatory activities

  • Tissue-targeted FasL through fusion with tissue-specific binding domains

• Detection-optimized variants:

  • Fluorescent fusion proteins for tracking FasL distribution and binding

  • Split reporter systems to monitor FasL-Fas interactions in real-time

  • Affinity-tagged variants for simplified purification and detection

These engineered proteins would provide researchers with more precise tools for investigating FasL biology.